We unleash your business potential by maximize the business innovation.
Send EmailMenaquinone, Vitamin K2, Menatetrenone, MK-4, MK-7, 863-61-6
| Parameter | Information |
|---|---|
| Chemical Name | Menaquinone |
| Other Names | Vitamin K2, Menatetrenone, MK-4, MK-7 |
| CAS Number | 863-61-6 |
| Chemical Formula | C₃₁H₄₀O₂ |
| Molecular Weight | 444.65 g/mol |
| Appearance | Yellowish crystals or oily liquid |
| Odor | Slight characteristic odor |
| Solubility | Soluble in fats and oils; insoluble in water |
| Vitamin Class | Fat-soluble vitamin |
| E Number | None (not classified as food additive) |
| Property | Value |
|---|---|
| Appearance | Yellowish crystalline or oily liquid |
| Chemical Formula | C₃₁H₄₀O₂ |
| Molecular Weight | 444.65 g/mol |
| CAS Number | 863-61-6 |
| Melting Point | 54 – 56 °C |
| Solubility in Water | Insoluble |
| Solubility in Fats/Oils | Soluble |
| Solubility in Ethanol | Soluble |
| Solubility in Chloroform | Soluble |
| Stability | Sensitive to light and oxygen |
| Storage | Protected from light, inert atmosphere |
| Shelf Life | 24 months (with proper storage) |
Chemical Structure:
Vitamin K2 (menaquinone) consists of a 2-methyl-1,4-naphthoquinone core with a side chain containing varying numbers of isoprene units. MK-4 and MK-7 are the most common forms.
IUPAC Name: 2-Methyl-3-(3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl)naphthalene-1,4-dione
SMILES: CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C
O
||
──── C ────
| |
H₃C─C C─CH₃
| |
──── C ────
||
O
| Type | Description | Source |
|---|---|---|
| MK-4 | Short-chain (4 isoprene units) | Animal sources, synthetic |
| MK-7 | Long-chain (7 isoprene units) | Fermented foods (natto) |
| MK-8 | 8 isoprene units | Fermented foods |
| MK-9 | 9 isoprene units | Fermented foods |
| MK-10 | 10 isoprene units | Fermented foods |
| Function | Mechanism | Description |
|---|---|---|
| Bone Health | Osteocalcin activation | Enables calcium binding to bones |
| Vascular Health | MGP (Matrix Gla Protein) activation | Prevents arterial calcification |
| Calcium Metabolism | Calcium routing | Ensures calcium is deposited in bones, not arteries |
| Synergy with D3 | D3 + K2 combination | D3 increases calcium absorption; K2 directs it to bones |
| Blood Clotting | Coagulation factors | Required for normal blood clotting |
| Cell Growth | Cell proliferation | Plays role in cell growth and differentiation |
| Antioxidant Effect | Free radical neutralization | Provides protection against oxidative stress |
| Feature | Vitamin K1 (Phylloquinone) | Vitamin K2 (Menaquinone) |
|---|---|---|
| Source | Green leafy vegetables | Fermented foods, animal products |
| Half-Life | Short (hours) | Long (MK-7: ~3 days) |
| Absorption | Low | High |
| Bone Health | Moderate | Strong |
| Vascular Health | Weak | Strong |
| Primary Role | Blood clotting | Calcium metabolism |
| Effect | Vitamin D3 | Vitamin K2 |
|---|---|---|
| Calcium Absorption | Increases | - |
| Calcium Transport | - | Directs to bones |
| Osteocalcin Activation | - | Activates |
| Vascular Calcification | May increase (alone) | Prevents |
| Bone Mineralization | Supports | Supports |
| Result | Calcium absorption increases | Calcium goes to the right place |
Summary: D3 increases calcium absorption, while K2 ensures calcium is directed to bones and prevents its accumulation in arteries. Their combined use exhibits a synergistic effect.
| Benefit | Description | Evidence Level |
|---|---|---|
| Osteoporosis Prevention | Increases bone density, reduces fracture risk | Clinical studies |
| Arterial Stiffness Prevention | Reduces arterial calcification | Clinical studies |
| Heart Health | Reduces cardiovascular risk | Epidemiological |
| Calcium Balance | Ensures proper calcium utilization | Biochemical |
| Dental Health | Contributes to tooth enamel strengthening | Preliminary studies |
| Insulin Sensitivity | May improve insulin sensitivity | Preliminary studies |
| Anti-inflammatory | May reduce inflammation | Animal studies |
| Symptom | Description |
|---|---|
| Osteoporosis | Decreased bone density |
| Vascular Calcification | Calcium accumulation in arteries |
| Dental Decay | Weakening of tooth enamel |
| Easy Bruising | Impaired blood clotting |
| Delayed Wound Healing | Slower tissue repair |
| Bone Fractures | Increased fracture risk |
| Source | Content (mcg/100g) | K2 Type |
|---|---|---|
| Natto | 1,000 – 1,100 | MK-7 |
| Goose Liver | 350 – 400 | MK-4 |
| Hard Cheeses | 50 – 80 | MK-4, MK-7 |
| Soft Cheeses | 30 – 50 | MK-4, MK-7 |
| Egg Yolk | 25 – 30 | MK-4 |
| Chicken | 10 – 20 | MK-4 |
| Beef | 5 – 10 | MK-4 |
| Salmon | 1 – 5 | MK-4 |
| Source | Content |
|---|---|
| Natto | Richest source |
| Sauerkraut | Low-Moderate |
| Kimchi | Low-Moderate |
| Kefir | Low |
| Application | Dosage | Form |
|---|---|---|
| Adults (Bone Health) | 45 – 90 mcg/day | Capsules, tablets, drops |
| Osteoporosis Treatment | 45 – 90 mcg/day | Capsules, tablets |
| Combination with D3 | 45 – 90 mcg K2 + 400-800 IU D3 | Capsules, tablets |
| MK-7 Form | 45 – 90 mcg/day | Capsules, drops |
| MK-4 Form | 1,500 – 10,000 mcg/day | Capsules, tablets |
| Food Fortification | 10 – 50 mcg/serving | Powder, liquid |
Note: There is a dosage difference between MK-4 and MK-7. MK-7 has a longer half-life and is effective at lower doses.
| Parameter | Information |
|---|---|
| Toxicity | Safe at normal doses |
| Oral LD50 (Rat) | > 10,000 mg/kg |
| Side Effects | None at normal doses |
| Overdose | May affect blood clotting |
| Anticoagulant Drugs | Use with caution (Warfarin, Coumadin) |
| Pregnancy | Safe (at recommended doses) |
| Breastfeeding | Safe (at recommended doses) |
| Drug Interactions | Blood thinners, antibiotics |
| Sector | Application | Description |
|---|---|---|
| Dietary Supplements | Osteoporosis, cardiovascular health | Widely used |
| Functional Foods | Fermented products, cheese, natto | Fortification |
| Pharmaceuticals | Osteoporosis treatment support | Formulations |
| Anti-Aging Support | Bone and vascular health | Supplementation |
| Sports Nutrition | Bone health, performance | Supplementation |
| Parameter | Information |
|---|---|
| Storage Conditions | Cool (15-25°C), dry, protected from light |
| Container Requirements | Tightly closed, inert gas atmosphere |
| Protect From | Light, oxygen, moisture, high heat |
| Shelf Life | 24 months (with proper storage) |
| Stability | Sensitive to light and oxygen |
| Region / Authority | Status |
|---|---|
| EFSA | Approved as food supplement |
| FDA | GRAS (Generally Recognized As Safe) |
| Turkey | Approved as food supplement |
| Codex | Approved as food supplement |
| Type | Name |
|---|---|
| Turkish Names | K2 Vitamini, Menakinon |
| English Names | Vitamin K2, Menaquinone, Menatetrenone |
| Forms | MK-4, MK-7, MK-8, MK-9, MK-10 |
| CAS Number | 863-61-6 |
| Parameter | Value |
|---|---|
| Product | Vitamin K2 (Menaquinone) |
| CAS Number | 863-61-6 |
| Formula | C₃₁H₄₀O₂ |
| Molecular Weight | 444.65 g/mol |
| Appearance | Yellowish crystals/oily liquid |
| Primary Applications | Bone health, vascular health, calcium metabolism |
1. FAT-SOLUBLE: Vitamin K2 is fat-soluble. Must be taken with dietary fat for optimal absorption.
2. ANTICOAGULANT DRUGS: Individuals taking Warfarin or other blood-thinning medications should consult their doctor before using K2 supplements. K2 may affect the efficacy of these drugs.
3. SYNERGY WITH D3: K2 exhibits synergistic effects with vitamin D3. D3 increases calcium absorption, while K2 directs it to bones.
4. LIGHT SENSITIVITY: Sensitive to light and oxygen. Store in dark-colored, tightly closed containers.
5. MK-4 vs MK-7: MK-7 has a longer half-life and is effective at lower doses. MK-4 requires higher doses.
6. STORAGE: Store in a cool, dry, light-protected environment under inert gas.
7. FOOD SOURCES: The richest natural source is natto (fermented soybeans), which contains high amounts of MK-7.
8. CALCIUM DIRECTOR: K2 ensures calcium goes to bones and prevents its accumulation in arteries. This property gives it the nickname "calcium traffic controller."
IMPORTANT DISCLAIMER: This Technical Data Sheet (TDS) is for informational purposes only and is prepared based on available technical data. This document is not a substitute for medical advice. For any health condition or supplement use, consult a healthcare professional. For complete safety, storage, use, and regulatory compliance information, refer to the official documentation provided by the manufacturer/supplier.